CCL4



CCL4

A1AA1P2PP2M3MM3G4GG4S5SS5D6DD6P7PP7P8PP8T9TT9A10AA10C11CC11C12CC12F13FF13S14SS14Y15YY15T16TT16A17AA17R18RR18K19KK19L20LL20P21PP21R22RR22N23NN23F24FF24V25VV25V26VV26D27DD27Y28YY28Y29YY29E30EE30T31TT31S32SS32S33SS33L34LL34C35CC35S36SS36Q37QQ37P38PP38A39AA39V40VV40V41VV41F42FF42Q43QQ43T44TT44K45KK45R46RR46S47SS47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations CCR5

No bioactivity data available.

CCL4

A1AA1P2PP2M3MM3G4GG4S5SS5D6DD6P7PP7P8PP8T9TT9A10AA10C11CC11C12CC12F13FF13S14SS14Y15YY15T16TT16A17AA17R18RR18K19KK19L20LL20P21PP21R22RR22N23NN23F24FF24V25VV25V26VV26D27DD27Y28YY28Y29YY29E30EE30T31TT31S32SS32S33SS33L34LL34C35CC35S36SS36Q37QQ37P38PP38A39AA39V40VV40V41VV41F42FF42Q43QQ43T44TT44K45KK45R46RR46S47SS47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations CCR5

Compound is not listed as a drug.